Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China
· Delayed Price · Currency is CNY 63.66
-0.33 (-0.52%)
At close: Dec 5, 2025
SHA:688336 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 39,265 | 13,212 | 13,884 | 7,833 | 11,431 | 15,190 | Upgrade
|
| Market Cap Growth | 155.35% | -4.84% | 77.24% | -31.47% | -24.75% | - | Upgrade
|
| Enterprise Value | 37,501 | 11,916 | 12,009 | 5,381 | 8,997 | 12,310 | Upgrade
|
| Last Close Price | 63.66 | 21.38 | 22.37 | 12.62 | 18.43 | 24.50 | Upgrade
|
| PE Ratio | 45.75 | 18.75 | 47.13 | 158.90 | 632.98 | - | Upgrade
|
| Forward PE | 128.17 | 36.46 | 104.70 | 145.14 | 85.29 | - | Upgrade
|
| PS Ratio | 28.66 | 11.07 | 13.69 | 9.49 | 12.31 | 23.19 | Upgrade
|
| PB Ratio | 6.70 | 2.39 | 2.85 | 1.70 | 2.52 | 3.36 | Upgrade
|
| P/TBV Ratio | 6.91 | 2.47 | 2.98 | 1.78 | 2.63 | 3.55 | Upgrade
|
| P/FCF Ratio | 14.81 | 37289.17 | 76.87 | 640.46 | - | - | Upgrade
|
| P/OCF Ratio | 13.49 | 46.99 | 33.35 | 33.55 | - | - | Upgrade
|
| EV/Sales Ratio | 27.37 | 9.98 | 11.84 | 6.52 | 9.69 | 18.79 | Upgrade
|
| EV/EBITDA Ratio | 43.36 | 35.67 | 41.80 | 63.38 | 337.42 | - | Upgrade
|
| EV/EBIT Ratio | 52.54 | 57.68 | 62.80 | - | - | - | Upgrade
|
| EV/FCF Ratio | 14.14 | 33631.43 | 66.49 | 439.99 | - | - | Upgrade
|
| Debt / Equity Ratio | - | 0.01 | 0.01 | 0.03 | - | - | Upgrade
|
| Debt / EBITDA Ratio | - | 0.15 | 0.17 | 1.77 | - | - | Upgrade
|
| Debt / FCF Ratio | - | 141.19 | 0.28 | 12.27 | - | - | Upgrade
|
| Asset Turnover | 0.19 | 0.21 | 0.20 | 0.17 | 0.19 | 0.16 | Upgrade
|
| Inventory Turnover | 1.48 | 1.44 | 1.06 | 0.94 | 0.97 | 0.52 | Upgrade
|
| Quick Ratio | 0.73 | 7.51 | 6.54 | 7.27 | 12.18 | 10.22 | Upgrade
|
| Current Ratio | 2.05 | 8.39 | 7.30 | 7.96 | 13.33 | 11.14 | Upgrade
|
| Return on Equity (ROE) | 15.74% | 13.28% | 5.98% | 0.99% | -0.04% | -6.35% | Upgrade
|
| Return on Assets (ROA) | 2.66% | 2.29% | 2.30% | -0.47% | -1.38% | -3.88% | Upgrade
|
| Return on Capital (ROIC) | 3.57% | 2.46% | 2.47% | -0.51% | -1.50% | -4.33% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.30% | 3.70% | 3.80% | -0.80% | -2.30% | -5.50% | Upgrade
|
| Earnings Yield | 2.22% | 5.33% | 2.12% | 0.63% | 0.16% | -1.43% | Upgrade
|
| FCF Yield | 6.75% | 0.00% | 1.30% | 0.16% | -4.44% | -1.76% | Upgrade
|
| Dividend Yield | 0.19% | 0.57% | 0.22% | - | - | - | Upgrade
|
| Payout Ratio | 6.48% | 7.43% | 0.50% | 2.48% | - | - | Upgrade
|
| Buyback Yield / Dilution | -1.15% | -0.70% | 0.40% | -2.37% | -2.42% | -10.22% | Upgrade
|
| Total Shareholder Return | -0.95% | -0.12% | 0.62% | -2.37% | -2.42% | -10.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.